Vitamin K epoxide reductase (VKOR) drives the vitamin K cycle, activating vitamin K-dependent blood clotting factors. VKOR is also the target of the widely used anticoagulant drug, warfarin. Despite
Analysis simulated dataset 2. This simulated dataset models an input with incomplete annotation of peptides required for exact calculation of abundance in the Analysis module of ProteoModlR. (CSV 5 kb